Stock Split History
ETFs Holding CTIC »    CTIC Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L. According to our CTI BioPharma stock split history records, CTI BioPharma has had 2 splits.
CTI BioPharma stock split history picture
CTI BioPharma (CTIC) has 2 splits in our CTI BioPharma stock split history database. The first split for CTIC took place on September 04, 2012. This was a 1 for 5 reverse split, meaning for each 5 shares of CTIC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split. CTIC's second split took place on January 03, 2017. This was a 1 for 10 reverse split, meaning for each 10 shares of CTIC owned pre-split, the shareholder now owned 1 share. For example, a 200 share position pre-split, became a 20 share position following the split.

When a company such as CTI BioPharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the CTI BioPharma stock split history from start to finish, an original position size of 1000 shares would have turned into 20 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CTI BioPharma shares, starting with a $10,000 purchase of CTIC, presented on a split-history-adjusted basis factoring in the complete CTI BioPharma stock split history. CTI BioPharma split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/26/2012
End date: 09/23/2022
Start price/share: $24.70
End price/share: $5.82
Dividends collected/share: $0.00
Total return: -76.44%
Average Annual Total Return: -13.46%
Starting investment: $10,000.00
Ending investment: $2,356.90
Years: 10.00
Date Ratio
09/04/20121 for 5
01/03/20171 for 10
CTIC is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CTRV Split History
CTRX Split History
CTSO Split History
CUR Split History
CVM Split History
CXM Split History
CYCC Split History
CYH Split History
CYTK Split History
CYTR Split History

Also explore: CTIC shares outstanding history

Email EnvelopeFree CTIC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
Iterum Therapeutics plc (ITRM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding CTI BioPharma
CTI BioPharma Insider Buying

CTI BioPharma Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.